Annual Accounts Receivable
$45.00 K
-$205.00 K-82.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX annual accounts receivable is $45.00 thousand, with the most recent change of -$205.00 thousand (-82.00%) on December 31, 2023.
- FRTX annual accounts receivable is now -99.24% below its all-time high of $5.89 million, reached on December 1, 2002.
Performance
FRTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$45.00 K
+$45.00 K+100.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX quarterly accounts receivable is $45.00 thousand, with the most recent change of +$45.00 thousand (+100.00%) on December 31, 2023.
- Over the past year, FRTX quarterly accounts receivable has increased by +$45.00 thousand (+100.00%).
- FRTX quarterly accounts receivable is now -99.59% below its all-time high of $11.05 million, reached on June 1, 2006.
Performance
FRTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
FRTX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.0% | +100.0% |
| 3 y3 years | - | +100.0% |
| 5 y5 years | -96.0% | +100.0% |
FRTX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.0% | at low | -87.9% | -100.0% |
| 5 y | 5-year | -82.0% | at low | -87.9% | -100.0% |
| alltime | all time | -99.2% | at low | -99.6% | -100.0% |
Fresh Tracks Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $45.00 K(-82.0%) | $45.00 K(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $45.00 K(-82.0%) |
| Dec 2022 | $250.00 K(+100.0%) | $250.00 K(-32.8%) |
| Sep 2022 | - | $372.00 K(+3.9%) |
| Jun 2022 | - | $358.00 K(+289.1%) |
| Mar 2022 | - | $92.00 K(-26.4%) |
| Dec 2021 | $125.00 K(-88.9%) | - |
| Dec 2021 | - | $125.00 K(-87.2%) |
| Jun 2019 | - | $979.00 K(+18.5%) |
| Mar 2019 | - | $826.00 K(-26.8%) |
| Dec 2018 | $1.13 M(-78.0%) | $1.13 M(-41.1%) |
| Sep 2018 | - | $1.92 M(+19.0%) |
| Jun 2018 | - | $1.61 M(+11.4%) |
| Mar 2018 | - | $1.45 M(-71.8%) |
| Dec 2017 | $5.12 M(+49.7%) | $5.12 M(+86.7%) |
| Sep 2017 | - | $2.75 M(-5.3%) |
| Jun 2017 | - | $2.90 M(-1.5%) |
| Mar 2017 | - | $2.94 M(-14.0%) |
| Dec 2016 | $3.42 M(-24.7%) | $3.42 M(-45.2%) |
| Sep 2016 | - | $6.25 M(+31.5%) |
| Jun 2016 | - | $4.75 M(+14.2%) |
| Mar 2016 | - | $4.16 M(-8.4%) |
| Dec 2015 | $4.54 M(+8.8%) | $4.54 M(-21.2%) |
| Sep 2015 | - | $5.77 M(+22.8%) |
| Jun 2015 | - | $4.70 M(+26.6%) |
| Mar 2015 | - | $3.71 M(-11.2%) |
| Dec 2014 | $4.18 M(-9.0%) | $4.18 M(-10.9%) |
| Sep 2014 | - | $4.69 M(+3.5%) |
| Jun 2014 | - | $4.53 M(+3.5%) |
| Mar 2014 | - | $4.38 M(-4.6%) |
| Dec 2013 | $4.59 M | $4.59 M(+151.0%) |
| Sep 2013 | - | $1.83 M(-12.2%) |
| Jun 2013 | - | $2.08 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $2.39 M(+11.1%) |
| Dec 2012 | $2.15 M(-31.2%) | $2.15 M(-31.2%) |
| Dec 2011 | $3.13 M(+233.0%) | $3.13 M(+233.0%) |
| Dec 2010 | $940.00 K(-25.5%) | $940.00 K(-43.0%) |
| Sep 2008 | - | $1.65 M(-27.4%) |
| Jun 2008 | - | $2.27 M(+38.1%) |
| Mar 2008 | - | $1.65 M(+30.5%) |
| Dec 2007 | $1.26 M(-75.0%) | $1.26 M(-5.0%) |
| Sep 2007 | - | $1.33 M(-69.4%) |
| Jun 2007 | - | $4.34 M(-0.8%) |
| Mar 2007 | - | $4.38 M(-13.3%) |
| Dec 2006 | $5.05 M(-12.6%) | $5.05 M(+13.9%) |
| Sep 2006 | - | $4.43 M(-59.9%) |
| Jun 2006 | - | $11.05 M(+10.4%) |
| Mar 2006 | - | $10.00 M(+73.1%) |
| Dec 2005 | $5.78 M(+69.3%) | $5.78 M(+27.5%) |
| Sep 2005 | - | $4.53 M(-7.4%) |
| Jun 2005 | - | $4.89 M(-1.1%) |
| Mar 2005 | - | $4.95 M(+45.0%) |
| Dec 2004 | $3.41 M(-27.2%) | $3.41 M(-10.9%) |
| Sep 2004 | - | $3.83 M(-32.7%) |
| Jun 2004 | - | $5.69 M(+7.9%) |
| Mar 2004 | - | $5.27 M(+12.4%) |
| Dec 2003 | $4.69 M(-20.4%) | $4.69 M(-11.8%) |
| Sep 2003 | - | $5.31 M(-3.1%) |
| Jun 2003 | - | $5.49 M(-11.8%) |
| Mar 2003 | - | $6.22 M(+5.5%) |
| Dec 2002 | $5.89 M(+27.1%) | $5.89 M(+37.7%) |
| Sep 2002 | - | $4.28 M(-4.3%) |
| Jun 2002 | - | $4.47 M(+4.9%) |
| Mar 2002 | - | $4.26 M(-8.0%) |
| Dec 2001 | $4.64 M(+5.0%) | $4.64 M(+66.1%) |
| Sep 2001 | - | $2.79 M(-14.2%) |
| Jun 2001 | - | $3.25 M(-36.2%) |
| Mar 2001 | - | $5.10 M(+15.6%) |
| Dec 2000 | $4.41 M | $4.41 M |
FAQ
- What is Fresh Tracks Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual accounts receivable year-on-year change?
- What is Fresh Tracks Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly accounts receivable year-on-year change?
What is Fresh Tracks Therapeutics annual accounts receivable?
The current annual accounts receivable of FRTX is $45.00 K
What is the all time high annual accounts receivable for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual accounts receivable is $5.89 M
What is Fresh Tracks Therapeutics annual accounts receivable year-on-year change?
Over the past year, FRTX annual accounts receivable has changed by -$205.00 K (-82.00%)
What is Fresh Tracks Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of FRTX is $45.00 K
What is the all time high quarterly accounts receivable for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly accounts receivable is $11.05 M
What is Fresh Tracks Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, FRTX quarterly accounts receivable has changed by +$45.00 K (+100.00%)